01110.HK
Kingworld Medicines Group Limited
HKSE · Healthcare · Medical - Pharmaceuticals · CN
HKD 0.37
−3.90%Year over year
Reported trailing growth
- Revenue
- -16.2%
- EBITDA
- +20.9%
- EBIT
- +40.8%
- EPS
- +90.9%
- Free cash flow
- +85.0%
- Operating cash flow
- +277.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.4%
- EBITDA
- -11.2%
- EBIT
- -4.4%
- Net income
- -20.8%
- EPS
- -20.0%
- Free cash flow
- -16.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026